Lilly Asia, Qiming, HongShan et al Double Down on Cell Therapy Tech
22 Oct 2024
US$ 19.00
Lilly Asia Ventures, Qiming Venture Partners, HongShan and FreesFund, all existing investors of XellSmart ......
Tag
Biotech
Related Publications
Anchorage Capital Partners (Anchorage) has invested in Entag Group Pty Ltd (Entag), an enterprise technology ......
Carma Ltd (Carma), a used-car platform backed by General Catalyst and Tiger Global Management LLC, was listed on ......
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.